Color Doppler signal enhancement with SH/TH-508 in pancreatic tumors

H. Imai; Y. Horiguchi; H. Kubo; T. Suzuki; K. Sakamoto; M. Uematsu; F. Takeuchi; H. Nakamura; T. Hayashi; A. Tokuda; M. Asano; J. Murai; K. Osakabe; Y. Kushi; T. Nishikawa; Y. Sugita; C. Soeshima

Color Doppler signal enhancement with SH/TH-508 in pancreatic tumors

H. Imai
, Y. Horiguchi
, H. Kubo
, T. Suzuki
, K. Sakamoto
, M. Uematsu
, F. Takeuchi
, H. Nakamura
, T. Hayashi
, A. Tokuda
, M. Asano
, J. Murai
, K. Osakabe
, Y. Kushi
, T. Nishikawa
, Y. Sugita
, C. Soeshima

Research output: Contribution to journal › Article › peer-review

Abstract

In this report, we showed the efficacy of a new contrast agent (SH/TA-508, Schering AG, Germany) for color Doppler imaging of the pancreatic tumors. In pancreatic ductal cancer, no enhancement of the lesion was observed, but vascular invasion by cancer became to be easily evaluated. On the other hand, hypervascular tumors such as islet cell tumor and cystadenocarcinoma, were increased in color Doppler signals of vessels by SH/TA-508. We concluded that SH/TA-508 was useful for evaluating the vascular invasion by pancreatic cancer as well as vascularity of hypervascular mass and solid component of cystic neoplasma.

Original language	English
Pages (from-to)	1018-1023
Number of pages	6
Journal	Nippon rinsho. Japanese journal of clinical medicine
Volume	56
Issue number	4
Publication status	Published - 04-1998
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

General Medicine

Cite this

@article{b5d87937a77b4ce588672f39a18a9b1e,

title = "Color Doppler signal enhancement with SH/TH-508 in pancreatic tumors",

abstract = "In this report, we showed the efficacy of a new contrast agent (SH/TA-508, Schering AG, Germany) for color Doppler imaging of the pancreatic tumors. In pancreatic ductal cancer, no enhancement of the lesion was observed, but vascular invasion by cancer became to be easily evaluated. On the other hand, hypervascular tumors such as islet cell tumor and cystadenocarcinoma, were increased in color Doppler signals of vessels by SH/TA-508. We concluded that SH/TA-508 was useful for evaluating the vascular invasion by pancreatic cancer as well as vascularity of hypervascular mass and solid component of cystic neoplasma.",

author = "H. Imai and Y. Horiguchi and H. Kubo and T. Suzuki and K. Sakamoto and M. Uematsu and F. Takeuchi and H. Nakamura and T. Hayashi and A. Tokuda and M. Asano and J. Murai and K. Osakabe and Y. Kushi and T. Nishikawa and Y. Sugita and C. Soeshima",

note = "Copyright: This record is sourced from MEDLINE{\textregistered}/PubMed{\textregistered}, a database of the U.S. National Library of Medicine",

year = "1998",

month = apr,

language = "English",

volume = "56",

pages = "1018--1023",

journal = "Nippon rinsho. Japanese journal of clinical medicine",

issn = "0047-1852",

publisher = "Nipponrinsho Co., Inc.",

number = "4",

}

TY - JOUR

T1 - Color Doppler signal enhancement with SH/TH-508 in pancreatic tumors

AU - Imai, H.

AU - Horiguchi, Y.

AU - Kubo, H.

AU - Suzuki, T.

AU - Sakamoto, K.

AU - Uematsu, M.

AU - Takeuchi, F.

AU - Nakamura, H.

AU - Hayashi, T.

AU - Tokuda, A.

AU - Asano, M.

AU - Murai, J.

AU - Osakabe, K.

AU - Kushi, Y.

AU - Nishikawa, T.

AU - Sugita, Y.

AU - Soeshima, C.

N1 - Copyright: This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

PY - 1998/4

Y1 - 1998/4

N2 - In this report, we showed the efficacy of a new contrast agent (SH/TA-508, Schering AG, Germany) for color Doppler imaging of the pancreatic tumors. In pancreatic ductal cancer, no enhancement of the lesion was observed, but vascular invasion by cancer became to be easily evaluated. On the other hand, hypervascular tumors such as islet cell tumor and cystadenocarcinoma, were increased in color Doppler signals of vessels by SH/TA-508. We concluded that SH/TA-508 was useful for evaluating the vascular invasion by pancreatic cancer as well as vascularity of hypervascular mass and solid component of cystic neoplasma.

AB - In this report, we showed the efficacy of a new contrast agent (SH/TA-508, Schering AG, Germany) for color Doppler imaging of the pancreatic tumors. In pancreatic ductal cancer, no enhancement of the lesion was observed, but vascular invasion by cancer became to be easily evaluated. On the other hand, hypervascular tumors such as islet cell tumor and cystadenocarcinoma, were increased in color Doppler signals of vessels by SH/TA-508. We concluded that SH/TA-508 was useful for evaluating the vascular invasion by pancreatic cancer as well as vascularity of hypervascular mass and solid component of cystic neoplasma.

UR - https://www.scopus.com/pages/publications/0032042216

UR - https://www.scopus.com/pages/publications/0032042216#tab=citedBy

M3 - Article

C2 - 9577627

AN - SCOPUS:0032042216

SN - 0047-1852

VL - 56

SP - 1018

EP - 1023

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

IS - 4

ER -

Color Doppler signal enhancement with SH/TH-508 in pancreatic tumors

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this